
Upon recognizing their specific antigen through the B cell receptor (BCR), B cells undergo a complex and tightly regulated process of activation. This activation is essential for initiating subsequent steps in antibody production, including clonal expansion and differentiation into various cell types. The activation process involves a cascade of intracellular signaling pathways triggered by the BCR complex. Following antigen binding, two primary signaling pathways are activated:
The B cell receptor (BCR) pathway: This pathway involves the activation of protein tyrosine kinases (PTKs) like Lyn and Syk. These PTKs, in turn, activate various downstream signaling molecules, including phospholipase C (PLCγ2). PLCγ2 hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers the release of calcium ions (Ca2+) from the endoplasmic reticulum, while DAG activates protein kinase C (PKC). This intricate interplay of signaling molecules ultimately leads to the activation of transcription factors like NF-κB, AP-1, and IRF4.
The co-stimulatory pathway: This pathway is typically triggered by the interaction between CD40 ligand on T helper cells and CD40 on B cells. This interaction activates various signaling molecules, including protein kinase A (PKA) and NF-κB.1,2
These activated transcription factors then enter the nucleus and bind to specific DNA sequences, promoting the transcription of a multitude of genes involved in various processes:
Cell proliferation: Genes encoding proteins necessary for cell division, such as cyclin-dependent kinases (Cdks), are activated, leading to clonal expansion of the B cell population. This generates a large number of daughter cells, all specifically targeting the same antigen.
Differentiation: Genes directing the differentiation of B cells into various types are also activated. These types include:
Plasma cells: These specialized cells dedicate their entire machinery to producing large quantities of antibodies specifically targeted against the encountered antigen.
Memory B cells: These long-lived cells remain dormant but retain the memory of the specific antigen encountered. Upon future exposure to the same antigen, they can rapidly differentiate into plasma cells, providing long-term immunity.
Antibody production: Genes encoding the specific antibody heavy and light chains are also activated. These chains are assembled and undergo modifications to form functional antibodies tailored to neutralize the antigen.3
Following activation, B cells undergo clonal expansion, a rapid cell division process that generates a large number of daughter cells. This process is tightly regulated by various factors, including:
Transcription factors: Activated transcription factors, such as Myc and E2F, promote the expression of genes essential for cell cycle progression and DNA replication.
Growth factors: Cytokines like interleukin-2 (IL-2) and interleukin-4 (IL-4) released by T helper cells further stimulate B cell proliferation.
Otipoby, K. L., Waisman, A., Derudder, E., Srinivasan, L., Franklin, A., & Rajewsky, K. (2015). The B-cell antigen receptor integrates adaptive and innate immune signals. Proceedings of the National Academy of Sciences of the United States of America, 112(39), 12145-12150. https://www.pnas.org/doi/full/10.1073/pnas.1516428112
Watts, T. H. (2004). TNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES. Annual Review of Immunology, 23:23-68. https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.23.021704.115839
Waters, L. R., Ahsan, F. M., Wolf, D. M., Shirihai, O., & Teitell, M. A. (2018). Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling. IScience, 5, 99-109. https://www.cell.com/iscience/fulltext/S2589-0042(18)30093-2
Learn how multivalent and bispecific VHH antibodies are engineered, their advant……
April 2026 activity saw consolidation in the ADC space, continued expansion of n……
Read on for key trends talked about during the conference: Antibody Therapeutics……
Explore VHH antibody humanization strategies, challenges, and validation methods……
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
Biointron uses cookies and similar technologies to ensure proper website functionality, understand how visitors use our website, and improve our content and services. Necessary cookies are enabled by default.
By clicking “Accept All”, you agree to the use of all cookies, including analytics and optional cookies that help us understand website usage and improve user experience. By clicking “Reject Non-Essential”, only necessary cookies will be used.
You may manage or change your cookie preferences at any time by clicking “Cookie Settings” at the bottom of the website.
For more information about how we use cookies and process personal data, please review our Privacy Policy.



